Psychiatric treatment: breaking new ground?
The Brown University Child and Adolescent Behavior Letter April 13, 2026 DOI: 10.1002/cbl.30949 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Key points | The text notes growing enthusiasm for diverse psychiatric treatments, including psychedelics, TMS, ECT, lesioning, and GLP-1s, but provides no specific results or conclusions. |
Abstract
Excitement has built recently about new avenues for psychiatric treatment: psychedelic drugs such as Ketamine and psilocybin; trans‐cranial magnetic stimulation (TMS). We see the revival of older practices such as electro‐convulsive shock therapy (ECT) and therapeutic lesioning, and medicines borrowed from other fields, like GLP‐1s.